## Table 3 |
||||

Comparison of percent of cells positive for CD11b/CADO48A by gate amongst tumor types |
||||

Sarcoma |
Mean |
Median |
Min |
Max |

Ungated | 33.4±12.7 | 28.7 | 13.5 | 58.2 |

R1 | 29.9±12.5* | 26.5 | 11.7 | 53.1 |

P1 | 29.0±12.6* | 25.5 | 11.6 | 51.8 |

P2 | 25.1±12.0 | 22.4 | 8.2 | 50.6 |

P3 | 4.8±4.7 | 3.5 | 1.6 | 20.3 |

P4 | 4.7±2.9 | 3.8 | 1.1 | 12.6 |

Carcinoma |
||||

Ungated | 30.4±14.8 | 23.8 | 11.4 | 64.5 |

R1 | 26.4±12.8* | 21.5 | 8.5 | 55.6 |

P1 | 25.3±12.5* | 21.0 | 7.2 | 53.6 |

P2 | 22.7±11.4 | 18.2 | 8.1 | 47.9 |

P3 | 3.7±1.9 | 3.1 | 1.2 | 8.0 |

P4 | 5.1±3.5 | 3.5 | 2.1 | 12.7 |

Melanoma |
||||

Ungated | 56.0±15.2 | 53.5 | 42.3 | 72.3 |

R1 | 52.6±13.5* | 51.0 | 40.0 | 66.9 |

P1 | 51.6±13.0* | 50.2 | 39.3 | 65.2 |

P2 | 44.7±13.5 | 41.2 | 33.3 | 59.6 |

P3 | 7.8±2.2 | 7.7 | 5.7 | 10.1 |

P4 | 4.8±1.1 | 4.5 | 3.8 | 6.0 |

The percentage of cells staining positive for CD11b and CADO48A are displayed for each tumor subtype: sarcoma (n= 19), carcinoma (n=18) and melanoma (n=3). Patients were categorized into one of the three groups based on either cytology or histopathology. A statistical difference was seen in the R1 and P1 gates between the 3 tumor types on initial analysis. When the melanoma patients were excluded due to low patient numbers no statistical difference was seen in the percent of CD11b/CADO48A positive cells, in any gate, between the sarcoma or carcinoma patients. An * denoted statistical significance (p<0.05). All values are expressed as a percentage of all cells analyzed by flow cytometry.

Sherger * et al.*

Sherger * et al.* *BMC Veterinary Research* 2012 **8**:209 doi:10.1186/1746-6148-8-209